The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
A key highlight will be Brenntag’s qualified amino acids portfolio
Data show adjuvant Verzenio plus endocrine therapy extends overall survival and sustains long-term improvements in invasive disease-free survival
Jaypirca is making waves in the fight against B-cell malignancies
The trials, designed to assess whether semaglutide could slow cognitive decline, showed no significant difference compared to placebo in the progression of Alzheimer’s disease over two years
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Abbott is eyeing to become a global powerhouse in early cancer detection and precision oncology
Subscribe To Our Newsletter & Stay Updated
